期刊文献+

血清胱抑素C水平与急性脑梗死严重程度的关系 被引量:6

Relationship between the Serum Cyst- C Level and Severity of the Acute Cerebral Infarction
原文传递
导出
摘要 目的:分析血清胱抑素C(Cyst—C)水平与急性脑梗死神经功能缺损严重程度的关系。方法:选择皖南医学院弋矶山医院神经内科2010年12月到2011年7月住院治疗的急性脑梗死患者398例,于人院后次晨测定血清Cyst—C,同时采用美国国立卫生研究院卒中量表(NIHSS)对患者入院时神经功能缺损程度进行评分。将患者分为轻度神经功能缺损(NIHSS〈4分)、中度神经功能缺损(NIHSS评分4~15分)、重度神经功能缺损(N1HSS评分〉15分),比较各组『HJ血清Cyst—C水平的差异,并分析神经功能缺损程度的相关因素。结果:轻度神经功能缺损152例,平均NIHSS为2.45分,中度神经功能缺损186例,平均NIHSS为10.05分,重度神经功能缺损60例,平均NIHSS为18.09分。轻度神经功能缺损血清Cyst—C水平0.93±0.46mmol/L,中度神经功能缺损血清Cyst—C水平1.13±0.35mmol/L,重度神经功能缺损m清Cyst—C水平1.43±0.75mm01/[。。神经功能缺损程度越重,血清Cyst—C水平越高,组问差异有统计学意义(P〈0.05),进一步行SNK—q检验,3组间两两比较,差异有统计学意义(P〈0.05),神经功能缺损程度与血清Cyst—C水平呈止相父(r=0.041,P〈0.01)。结论:血清Cyst—C水平与急性脑梗死的神经功能缺损程度相关。血清Cyst—C是急性脑梗死的独立危险因素,也是对脑梗死后神经功能缺损程度预后的预测指标之一。治疗高血清Cyst—C血症既可以预防脑梗死,又对改善脑梗死预后起到重要的作用。 OBJECTIVE : To analyze the relationship between serum Cyst - C level and dysneuria tollowing acute cerebral infarction. METHODS: 398 patients after acute cerebral infarction were selected from the department of neurology. Cyst - C level was measured the next morning and dysneuria was scored by NIHSS. Then the patients were divided into 3 groups : the light group ( NIH- SS 〈4, n = 152), the moderate group ( NIHSS 4 - 15, n = 186) and the severe group ( NIHSS 〉 15, n =60). The Cyst - C levels in three groups were compared. Related factors of this disease were analyzed at last. RESULTS : Average NIHSS score in light group was 2.45 and the Cyst - C level was 0. 93 ± 46mmol/L. Average NIHSS score was 10. 05 and the Cyst - C level was 1.13 ± 0. 35mmol/L. NIHSS score in the severe group was 18.09 ( 1.43 ±0. 75) mmol/L and the serum Cyst - C level was raised with neu- rological impairment (P 〈 0. 05 ). The degree of neurological impairment was positive correlation with the serum Cyst- C level (r = 0. 041, P 〈 0. 01 ). CONCLUSIONS: The study suggests that the degree of dysneuria is related with serum Cyst - C level, which in- dicates that Cyst - C level is independently the risk factor of the acute cerebral infarction and one of the predicting index of dysneuria. So Reducing elevated serum Cyst - C levels may prevent acute cerebral infarction and improve the prognosis of it.
出处 《国际老年医学杂志》 2012年第3期102-105,共4页 International Journal of Geriatrics
关键词 脑梗死 胱抑素C 神经功能缺损 Cerebral infarction Cyst - C Neurologic deficits
  • 相关文献

参考文献11

  • 1李京华,李江,曹宁,窦薇青,赵兴波,陈向东.急性脑梗死患者血同型半胱氨酸及胱氨酸蛋白酶抑制剂C水平变化及意义[J].中国神经免疫学和神经病学杂志,2008,15(4):282-284. 被引量:46
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33037
  • 3Korolenko TA. Cystatins: biological role and changes in pathology [ J ]. Vestn Ross Akad Med Nauk, 2008, 13 (4): 43-47.
  • 4Chew JS, Saleem M, Florkowski CM, et al. Cystatin C - a paradigm of evidence based laboratory medicine [J]. Clin Biochem Rev, 2008, 29 (2): 47 -62.
  • 5Taglieri N, Koenig W, Kaski JC. Cystatin C and car- diovascular risk [ J]. Ann Biol Clin (Paris) , 2010, 68 (5): 517 -529.
  • 6汪飞,储照虎.胱抑素C与缺血性脑血管病相关性的研究进展[J].卒中与神经疾病,2010,17(5):309-311. 被引量:12
  • 7Shlipak MG, Sarnak M J, and the risk of death and elderly persons Katz R, et al. Cystatin C cardiovasular events among[ J ]. N Engl J Med, 2005, 352(20) : 2049 - 2060.
  • 8Seliger SL, longstreth WT, Katz R, et al. Cystatin C and subclinical brain infarction [ J ]. J Am Soc Neph- rol, 2005, 16 (21): 3721 -3727.
  • 9del Zoppp G J, Mabuchi T. Cerebral microvessel re- sponses to fbcal ischemia [ J ]. J Cereb Blood Flow Metab, 2003, 23 (8): 879-894.
  • 10章兴甫.脑梗死患者血清中炎症因子禽量的变化与临床神经功能缺损程度的关系.巾困临床医药研究杂志,2008,19(2):7-9.

二级参考文献41

  • 1仓志兰,姜亚军.炎性细胞因子与缺血性脑卒中[J].临床荟萃,2005,20(11):652-654. 被引量:14
  • 2史清海,路西春.胱抑素C的生物学特性及其测定的临床应用[J].西北国防医学杂志,2005,26(6):445-447. 被引量:33
  • 3何志勇,张雄,王小同.脑梗死患者血浆同型半胱氨酸变化及叶酸的干预作用[J].实用医学杂志,2006,22(9):1003-1005. 被引量:7
  • 4方军,洪灵敏.急性脑梗死患者血清胆红素和胱抑素C水平变化及意义[J].中国实验诊断学,2007,11(6):835-836. 被引量:35
  • 5Uno H,Matsuyama T,Akita H,et al.Induction of tumor necrosis factoy-αin the mouse hippocampus following transient forebrain is chemia[J].J Cereb Blood Flow Metab,1997,l7(5):491.
  • 6Liu J,Ginis I,Spatz M,et al.Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNFαand ceramide[J].Am J Physiol Cell Physiol,2000,278(1):C144.
  • 7Chew JS, Saleem M, Florkowski CM, et al. Cystatin C a paradigm of evidence based laboratory medicine. Clin Biochem Rev,2008, 29(2) :47-62.
  • 8Janow ski R, Kozakm, Jankow ska e, et al. Human cystatin C, amyloidogenic protein dimorizes though three dimensional domain swapping. Mat struct Biol,20(}1,8(4) ~316-320.
  • 9Hock FJ, Korevaar JC, Dekker FW, et al. Estimation of residual glomerular filtration rate in dialysis patients from the plasma cys tatin c leval. Nephrol Dial Transplant,2007,22(6) : 1633-1638.
  • 10Turk V, Stoka V,Turk D, et al. Cystatins: biochemical and structural properties, and medical relevance. Front Biosci, 2008, 13 (1) : 5406-5420.

共引文献33087

同被引文献50

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部